Associations between timing of exposure to ultraviolet radiation, T-stage and survival in prostate cancer

Cancer Detection and Prevention

Volumn 31, Issue 6, 2007, Pages 443-449

  Rukin, Nick ^a,b   Blagojevic, Miliça ^c   Luscombe, Christopher J ^b   Liu, Samson ^b   Saxby, Mark F ^b   Ramachandran, Sudarshan ^d   Fryer, Anthony A ^a   Jones, Peter W ^c   Strange, Richard C ^a  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Prostate cancer; Skin type; Survival; T stage; Ultraviolet radiation

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; GLEASON SCORE; HAZARD ASSESSMENT; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RADIATION EXPOSURE; RISK ASSESSMENT; SKIN; SUNLIGHT; SURVIVAL TIME; ULTRAVIOLET RADIATION;

AGED; ANDROGEN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SKIN PIGMENTATION; ULTRAVIOLET RAYS;

EID: 36549068245     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2007.10.017     Document Type: Article

References (35)

1. Ballentine H.C., and Partin A. Diagnosis and staging of prostate cancer. In: Walsh P.C. (Ed). Campbell's urology (2002), Saunders, Philadelphia 3055-3064
2. Ekman P., Pan Y., Li C., and Dich J. Environmental and genetic factors: a possible link with prostate cancer. Br J Urol 2 79 Suppl (1997) 35-41
3. Boscoe F.P., and Schymura M.J. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002. BMC Cancer 6 (2006) 264
4. Hanchette C.L., and Schwartz G.G. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70 (1992) 2861-2869
5. Schwartz G.G., and Hanchette C.L. UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States). Cancer Causes Control 17 (2006) 1091-1101
6. Grant W.B. A multicountry ecologic study of risk and risk reduction factors for prostate cancer mortality. Eur Urol 45 (2005) 271-279
7. Colli J.L., and Colli A. International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels. Urol Oncol 24 (2006) 184-194
8. John E.M., Dreon D.M., Koo J., and Schwartz G.G. Residential sunlight exposure is associated with a decreased risk of prostate cancer. J Steroid Biochem Mol Biol 89-90 (2004) 549-552
9. Luscombe C.J., Fryer A.A., French M.E., Liu S., Saxby M.F., Jones P.W., et al. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 358 (2001) 641-642
10. Van der Rhee H.J., de Vries E., and Coebergh J.W. Does sunlight prevent cancer? A systematic review. Eur J Cancer 42 (2006) 2222-2232
11. Luscombe C.J., French M.E., Liu S., Saxby M.F., Jones P.W., Fryer A.A., et al. Outcome in prostate cancer associations with skin type and polymorphism in pigmentation-related genes. Carcinogenesis 22 (2001) 1343-1347
12. Lagunova Z., Porojnicu A.C., Dahlback A., Berg J.P., Beer T.M., and Moan J. Prostate cancer survival is dependent on season of diagnosis. Prostate 67 (2007) 1362-1370
13. John E.M., Koo J., and Schwartz G.G. Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev 16 (2007) 1283-1286
14. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16 (2005) 83-95
15. Bodiwala D., Luscombe C.J., Liu S., Saxby M.F., French M.E., Jones P.W., et al. Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlight. Cancer Lett 192 (2003) 145-149
16. Rukin N.J., Zeegers M.P., Ramachandran S., Luscombe C.J., Liu S., Saxby M., et al. A comparison of sunlight exposure parameters in men with prostate cancer and basal cell carcinoma. Br J Cancer 96 (2007) 523-528
17. Gleason D.F. Histologic grading of prostate cancer: a perspective. Hum Pathol 23 (1992) 273-279
18. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types 1 through VI. Arch Dermatol 124 (1988) 869-871
19. de Vries E., Soerjomataram I., Houterman S., Louwan M.W., and Coebergh J.W. Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation?. Am J Epidemiol 165 (2007) 966-972
20. Tuohimaa P., Pukkala E., Scelo G., Olsen J.H., Brewster D.H., Hemminki K., et al. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explaination. Eur J Cancer 43 (2007) 1701-1712
21. Studzinski G.P., and Moore D.C. Sunlight-can it prevent as well as cause cancer?. Cancer Res 55 (1995) 4014-4022
22. Schwartz G.G. Vitamin D and the epidemiology of prostate cancer. Semin Dial 18 (2005) 276-289
23. Holick M.F. The vitamin D epidemic and its health consequences. J Nutr 135 (2005) 2739S-2748S
24. Harrison G.I., and Young A.R. Ultraviolet radiation-induced erythema in human skin. Methods 28 (2002) 14-19
25. Soos K., Tsakiris I.I., Szanto J., Turzo C., Gabriel P.H., and Dezso B. The prevalence of prostate carcinoma and its precursors in Hungary: an autopsy study. Eur Urol 48 (2005) 739-744
26. Caron-Schreinemachers A.J., Kingswijk M.M., Bos J.D., and Westerhof W. UVB 311 nm tolerance of vitiligo skin increases with skin photo type. Acta Derm Venereol 85 (2005) 24-26
27. Ziegler A.G., Baumgartl H.J., Ede G., Held M., Vogt H.J., Kolb H.J., et al. Low-pigment skin type and predisposition for development of type 1 diabetes. Diabetes Care 13 (1990) 529-531
28. Albertsen P.C., Hanley J.A., Barrows G.H., Penson D.F., Kowalczyk P.D.H., Sanders M., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 17 (2005) 1248-1253
29. Koksal I.T., Ozcan F., Kadioglu T.C., Esen T., Kilicasian I., and Tunc M. Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens. Eur Urol 37 (2000) 670-674
30. English D.R., Armstrong B.K., and Kricker A. Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol Biomarkers Prev 7 (1998) 857-863
31. Oh C., Hennessy A., Ha T., Bisset Y., Diffey B., and Rees J.L. The time-course of photoadaption and pigmentation studied using a novel method to distinguish pigmentation from erythema. J Invest Dermat 123 (2004) 965-972
32. Ponsonby A.L., and Dwyer T. Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis. Cancer Epidemiol Biomarkers Prev 15 (2006) 1538-1544
33. Grant W.B., and Garland C.F. The association of solar radiation B (UVB) with reducing risk of cancer: a multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26 (2006) 2687-2699
34. Schwartz G.G. The 'Cocaine Blues' and other problems in epidemiologic studies of vitamin D and cancer. Nutr Rev 65 (2007) S75-S76
35. Whitlach L.W., Young M.V., Schwartz G.G., Flanagan J.N., Burnstein K.L., Lokeshwar B.L., et al. 25-Hydroxy vitamin D-1-alpha-hydroxylase is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol 81 (2002) 135-140